Tokyo, Jan. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060363) titled 'Efficacy of ALK-TKIs for IHC-positive/Multiplex-negative ALK lung cancer' on Jan. 16.
Study Type:
Observational
Primary Sponsor:
Institute - Kyushu University
Condition:
Condition - Non-small cell lung cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - The objective of this study is to evaluate the efficacy of ALK inhibitors in ALK fusion-positive lung cancer that tested negative by multiplex testing but positive by IHC, and to examine the positivity rate of ALK fusions using other testing modalities.
Basic objectives2 - Efficacy
Eligibility:
Age-lower l...